114 related articles for article (PubMed ID: 15134368)
1. Model of angiogenesis in mice with severe combined immunodeficiency (SCID) and xenoengrafted with Epstein-Barr virus-transformed B cells.
Woodford NL; Call DR; Remick DG; Rochford R
Comp Med; 2004 Apr; 54(2):209-15. PubMed ID: 15134368
[TBL] [Abstract][Full Text] [Related]
2. Lack of pseudotype formation between human immunodeficiency virus type 1 and Epstein-Barr virus in productively coinfected B lymphoblastoid cell lines.
Van Kuyk R; Mosier DE
Virology; 1995 Jun; 209(2):643-8. PubMed ID: 7778296
[TBL] [Abstract][Full Text] [Related]
3. [Molecular pathological characteristics of human B-cell lymphomas induced by Epstein-Barr virus].
Gan RL; Yin ZH; Liu TF; Dong BH; Zhou JG; Yao KT
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Oct; 35(10):925-9. PubMed ID: 14515211
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity among Epstein-Barr virus-seropositive donors in the generation of immunoblastic B-cell lymphomas in SCID mice receiving human peripheral blood leukocyte grafts.
Picchio GR; Kobayashi R; Kirven M; Baird SM; Kipps TJ; Mosier DE
Cancer Res; 1992 May; 52(9):2468-77. PubMed ID: 1314693
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus-infected marmoset cells transfected with c-myc do not form lymphomas in mice with severe combined immunodeficiency.
Salimi B; O'Gorman MR; Variakojis D; Bendet M; Newman M; Poupko E; Katz BZ
Mol Genet Metab; 1998 Jul; 64(3):205-12. PubMed ID: 9719630
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus-infected marmoset cells do not form lymphomas in mice with severe combined immunodeficiency.
Katz BZ; Salimi B; Saini U; McNamara JG; Eisen R
Pediatr Res; 1994 Oct; 36(4):456-60. PubMed ID: 7816520
[TBL] [Abstract][Full Text] [Related]
7. Bcl-2 antisense oligodeoxynucleotide therapy of Epstein-Barr virus-associated lymphoproliferative disease in severe combined immunodeficient mice.
Guinness ME; Kenney JL; Reiss M; Lacy J
Cancer Res; 2000 Oct; 60(19):5354-8. PubMed ID: 11034070
[TBL] [Abstract][Full Text] [Related]
8. Human-->mouse radiation chimera do not develop Epstein-Barr virus lymphoma.
Marcus H; Burakova T; Shezen E; David M; Canaan A; Lubin I; Reisner Y
Immunol Lett; 1996 Mar; 49(3):155-61. PubMed ID: 8739310
[TBL] [Abstract][Full Text] [Related]
9. Role of IL-6 in promoting growth of human EBV-induced B-cell tumors in severe combined immunodeficient mice.
Durandy A; Emilie D; Peuchmaur M; Forveille M; Clement C; Wijdenes J; Fischer A
J Immunol; 1994 Jun; 152(11):5361-7. PubMed ID: 8189054
[TBL] [Abstract][Full Text] [Related]
10. Tumor outgrowth in peripheral blood mononuclear cell-injected SCID mice is not associated with early Epstein-Barr virus reactivation.
Piovan E; Bonaldi L; Indraccolo S; Tosello V; Menin C; Comacchio F; Chieco-Bianchi L; Amadori A
Leukemia; 2003 Aug; 17(8):1643-9. PubMed ID: 12886254
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus lymphoblastoid cell lines from transplanted patients induce B lymphomas in SCID/hu mice: study of EBV replication.
Blanc-Brunat N; Laurin D; Vivier G; Touraine JL; Sergeant A; Garnier JL
Transplant Proc; 1995 Apr; 27(2):1776. PubMed ID: 7725498
[No Abstract] [Full Text] [Related]
12. EBV-induced human B cell lymphomas in hu-PBL-SCID mice.
Mosier DE; Picchio GR; Kirven MB; Garnier JL; Torbett BE; Baird SM; Kobayashi R; Kipps TJ
AIDS Res Hum Retroviruses; 1992 May; 8(5):735-40. PubMed ID: 1325170
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of HHV-8/KSHV infected primary effusion lymphomas in NOD/SCID mice by azidothymidine and interferon-alpha.
Wu W; Rochford R; Toomey L; Harrington W; Feuer G
Leuk Res; 2005 May; 29(5):545-55. PubMed ID: 15755507
[TBL] [Abstract][Full Text] [Related]
14. [Model of B immunoblastic lymphomas in the Hu-PBL-SCID mice].
Chen DQ; Bai LJ; Liu QF; Cui LX; He W; Ba DN
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Jun; 25(3):294-6. PubMed ID: 12905742
[TBL] [Abstract][Full Text] [Related]
15. Simvastatin induces apoptosis of Epstein-Barr virus (EBV)-transformed lymphoblastoid cell lines and delays development of EBV lymphomas.
Katano H; Pesnicak L; Cohen JI
Proc Natl Acad Sci U S A; 2004 Apr; 101(14):4960-5. PubMed ID: 15041742
[TBL] [Abstract][Full Text] [Related]
16. Combination immunotherapy of B-cell non-Hodgkin's lymphoma with rituximab and interleukin-2: a preclinical and phase I study.
Eisenbeis CF; Grainger A; Fischer B; Baiocchi RA; Carrodeguas L; Roychowdhury S; Chen L; Banks AL; Davis T; Young D; Kelbick N; Stephens J; Byrd JC; Grever MR; Caligiuri MA; Porcu P
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6101-10. PubMed ID: 15447996
[TBL] [Abstract][Full Text] [Related]
17. Evolution of clonality and invasive behavior of Epstein-Barr virus immortalized lymphoblastoid cell lines in SCID mice brains.
Bashir R; Masih A; Kallweit K; Fordyce-Boyer R; Sanger W; Purtilo D
Lab Invest; 1992 Oct; 67(4):450-6. PubMed ID: 1331608
[TBL] [Abstract][Full Text] [Related]
18. Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder.
Roychowdhury S; Baiocchi RA; Vourganti S; Bhatt D; Blaser BW; Freud AG; Chou J; Chen CS; Xiao JJ; Parthun M; Chan KK; Eisenbeis CF; Ferketich AK; Grever MR; Chen CS; Caligiuri MA
J Natl Cancer Inst; 2004 Oct; 96(19):1447-57. PubMed ID: 15467034
[TBL] [Abstract][Full Text] [Related]
19. Heterotransplantation of human multiple myeloma cell lines in severe combined immunodeficiency (SCID) mice.
Tong AW; Huang YW; Zhang BQ; Netto G; Vitetta ES; Stone MJ
Anticancer Res; 1993; 13(3):593-7. PubMed ID: 8391243
[TBL] [Abstract][Full Text] [Related]
20. Human pathogenic Mycoplasma species induced cytokine gene expression in Epstein-Barr virus (EBV)-positive lymphoblastoid cell lines.
Schäffner E; Opitz O; Pietsch K; Bauer G; Ehlers S; Jacobs E
Microb Pathog; 1998 Apr; 24(4):257-62. PubMed ID: 9533897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]